Liuwei Dihuang Pills Enhance the Effect of Western Medicine in Treating Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials

Table 10

Analysis of the score of UAER.

Trials		MD (95% CI)	value
LDP plus Western drugs versus Western drugs
LDP plus routine treatment versus routine treatment	1	−51.30 [−64.13, −38.47]	<0.00001
LDP plus routine treatment versus routine treatment	1	−34.40 [−44.40, −24.40]	<0.00001
LDP plus routine treatment versus routine treatment	1	−24.88 [−37.94, −11.82]	0.0002
LDP plus routine treatment versus routine treatment	1	−44.40 [−46.59, −42.21]	<0.00001
Meta-analysis	4	−43.65 [−45.73, −41.58]	<0.00001
LDP plus Losartan Potassium plus Losartan Potassium	1	−27.76 [−30.70, −24.82]	<0.00001
LDP plus Losartan Potassium plus Losartan Potassium	1	−24.81 [−31.67, −17.95]	<0.00001
Meta-analysis	2	−27.30 [−30.01, −24.60]	<0.00001
LDP plus captopril plus routine treatment versus captopril plus routine treatment	1	−42.84 [−56.40, −29.28]	<0.00001
LDP plus valsartan dispersible plus routine treatment versus valsartan dispersible plus routine treatment	1	−3.51 [−5.81, −1.21]	0.003
Meta-analysis	2	−4.61 [−6.88, −2.34]	<0.0001